You are browsing the archive for biotech.

Upcoming Biotech Conferences & Events 2010

February 25, 2010 in Events by f3 fund it

It took some time, but we’ve put together a list of what we assume are the most relevant events and conferences for the Biotech Entrepreneur. We say relevant for the entrepreneur because we have left out conferences on clinical / drug development, medical conferences, etc… and if you think we missed anything let us know.

BIO-Europe Spring
March 8-10, 2010
Barcelona, Spain

Business for Scientisits
April 12-16, 2010
Chicago, IL, USA

BIO Legislative Day Fly-In 2010
April 13 – 14, 2010
Washington D.C., USA

BIO Intellectual Property Counsels Spring Conference and Committee Meeting
April 19-21, 2010
New Orleans, LA, USA

INTERPHEX 2010
April 20-22, 2010
New York, NY, USA

BIO-LES Business Development Basics Course
May 1-3, 2010
Chicago, IL, USA

Partnering for Global Health Forum
May 3, 2010
Chicago, IL, USA

BIO Executive Presentation Workshop
May 3, 2010
Chicago, IL, USA

BIO International Convention
May 3-6, 2010
Chicago, IL, USA

2010 BIO Human Resources Conference
May 5-7, 2010
Chicago, IL, USA

11th Annual BioEquity Europe
May 19-20, 2010
Zurich, Switzerland

Euro MedTech
June 1, 2010
Leipzig, Germany

ChinaBio Partnering Forum
June 23-24, 2010
Souzhou, China

The World Congress on Industrial Biotechnology and Bioprocessing
June 27-30, 2010
Washington, DC

BioParama America
September 15-17, 2010
Boston, MA, USA

BIO India International Partnering Conference
September 21-22, 2010
Hyderabad, India

Livestock Biotech Summit
September 28-30, 2010
Sioux Falls, SD, USA

9th Annual BIO Investor Forum
October 6-7, 2010
San Francisco, CA, USA

AdvaMed 2010
October 18-20, 2010
Washington D.C., USA

BIO-Europe International Partnering Conference
November 15-17, 2010
Munich, Germany

If you know of any other and worthwhile conferences or talks for the startup Biotech entrepreneur, let us know, and we will add to this list. Additionally, in terms of pure biotech-medical-pharma research. Head over to BioSpace – a really deeply designed database for the Life sciences community.

The Need for Competitive Intelligence

February 23, 2010 in General Business, Strategy by f3 fund it

Competitive Intelligence? What’s competitive intelligence? According to Wikipedia “Competitive intelligence (CI) is the action of defining, gathering, analyzing, and distributing intelligence about products, customers, competitors and any aspect of the environment needed to support executives and managers in making strategic decisions for an organization“.

Clearly though this defines any organization, however, it is typically interpreted as some classified top super secret information on your competition and utilized to gain a competitive advantage. Sure it could be that, however, we’d like to think that CI is an ongoing process that defines the market sphere and accumulates relevant knowledge that can be put to use by members of the company and board in formulating a concise strategy.

So how does or should a startup go about collecting CI, read, talk, visit trade shows, collect “relevant” information on the industry, as well as other industries that directly affect yours. i.e. if a new technology launches which can lower your production costs, see if you can implement it, your competitor may not be able to or may not know the new complimentary technology was launched, and you can beat them on price. Starting to see the need for CI now?

That said – different industries need different levels of CI, that in a number of ways are relevant to the following factors.

Competitive Intelligence Criteria

1. Level of capital investment – low investment startups need worry less about CI than ones requiring a million+ to get to market? Why? Simple, with little investment your clients should be virtually at your doorstep. If you have long lead times, and are in a competitive industry, well… there’s a good change there exist a few competitors trying to do the same thing you are.

2. The Blue Ocean approach – if your business is simply not looking at your market’s competition and going after an entirely new or competitor irrelevant market segment (think MSFT XBox, Sony PS3, Nintendo Wii), your level of CI involvement may not have to be as high as other industry competitors. In the above example, Nintendo basically made the Xbox and PS3 irrelevant as they targeted a totally different type of home video game user. Notwithstanding, this approach requires a deep understanding of the industry.

3. Identifying specific types of CI – are partnerships necessary, is your business based on intellectual property (IP) or perhaps human capital? Are there technology opportunities, risks? Identify and assign roles to each to base and develop your CI strategy. There is after all no need to expend resources where they are not needed.

However since, we’re focusing on Biotech this week, we found a great list of CI requirements at nature.com for any Biotech Startup, the list can be found via above link and continues now.

Types of Competitive Intelligence

1. Intellectual property. Depending on the company’s resources, one should do a comprehensive patent literature search at least once a year. When searching for patents, it is useful to start with the European Patent Office, which publishes all patent applications within 18 months of when they are filed, usually after one year, whereas the USPTO will not publish patents until 18 months after they are filed. This is valuable information, because most countries do not make a patent available to the public until it has been reviewed by the patent office.

2. Market need and size. Identifying target market segments will allow the company to know what markets competitors are planning to move into or are ignoring. During the long development periods required for most biotech products, the market needs and size will change. It is therefore vital to keep CI up to date by regularly consulting with key people, such as members of a carefully chosen Scientific Advisory Board and a broad sample of experts in the relevant fields. Networking at professional or industry conferences is a good way to do this.

3. Partnerships. By monitoring new technologies entering the market and in development, the company can identify possible partnerships with other companies and academic institutions. Scientific journal and patent literature searches along with professional conferences can all be potentially fruitful sources of new partners.

4. Competitive environment. It is important to continuously monitor the competition. Some players will drop out, while new, potentially disruptive technologies developed by small firms may enter the market that may not be readily apparent as competitors. The company has to be very expansive in thinking about the possible kinds of competitors. By attending conferences and examining relevant ads, the company can assess competitors’ product strategies.

5. Marketing and distribution. By talking with distributors’ and competitors’ sales forces, the company can determine how competitors are getting their products to market. This information can help the company develop its own more efficient and targeted strategy for product marketing and distribution. The company can, for example, look at how much competitors spend on advertising or how big competitors’ sales forces are to create benchmarks for its own goals and performance. Although most people will decline to talk to a “competitor,” many will talk to their “peers” in other companies if the questions are asked in the right way.

6. Technology opportunities and risks. By reading the publications of competitors’ scientists and their academic partners and talking with them at conferences, the company can identify the bottlenecks that competitors have encountered when developing similar technologies.

7. Regulatory and reimbursement issues. Surveying the regulatory agencies is one way to determine the current regulatory requirements and identify new issues that might affect the approval of a product or the way it is labeled and marketed. With a CI process one can examine the various factors in the regulatory environment and anticipate changes that may profoundly affect the enterprise.

8. Financing options. One of the most vital tasks for the leader of any startup is ensuring the resources that the firm needs to operate are available. CI can help determine which venture capitalists are investing in the firm’s technology area and what organizations might be interested in acquiring those technologies. This data can better establish the value of a company during financing and can potentially strengthen a firm’s negotiating position. In addition, CI can be used in examining merger and acquisition candidates, government grants and joint-venture partners that could provide alternative sources of funding, thereby increasing the firm’s negotiation leverage.

9. Human capital. Salary surveys and analyses of job ads can provide important insights into competitors’ staffing strategies. Likewise, recruiting agencies, while keeping their client information confidential, may be good sources for industry skill trends and the strategies of non-client firms. This kind of information can allow the company to determine the type of people it needs to succeed in a market niche and what it will take to attract and retain them.

In all CI is a vital part of any business, and as mentioned before should be an ongoing and active process at all organizations, we oftentimes forget that we’re conducting it by talking to people, networking and reading up on relevant industry literature. But the rub is, that if you’re not actively participating in it, you will loose your competitive advantage. Take our recommendation, and have a talk about it at your next board meeting and have one person in the company actively collect CI and make strategic recommendations based on those findings.

Podcast: Starting a Biotech Company

February 23, 2010 in Entrepreneurship, General Business, Statups by f3 fund it

How do you start a Biotech Company? Good question, for the most part it’s like anything else, you have a good idea, you write a business plan using a well defined guide, and then proceed to get things off the ground.

But we’ll let someone explain it better than we could, this podcast comes from Absolute Science and Welltopia.com where Mignon Fogarty interviews her husband Patrick Fogarty a post-doc at Stanford who in the 90’s started his own Biotech Firm with next to no knowledge of business. However you’ll notice a lot of the same trends we’ve been discussing here, engaging executive summary, a hook for the VC, scalability, market size and identification, thus further pinning the belief that a majority of entrepreneurial concepts are transferable between industries.

->> Listen to the podcast <<-

VIDEO Series: The Invisible Revolution – Biotechnology

February 23, 2010 in Video Series by f3 fund it

Biotech is dead, long live biotech.

The Wall Street Journal claimed in 2009 that it was a dire time for the biotech industry. New firms had little cash, and the outlook was grim indeed, then come January 2010 and we see a report indicating that the industry raised a record breaking $55.8 bn, yes billion, despite unfriendly capital markets. Why, we’ll cover that later on today but for now, we’d like to introduce you to the Invisible Revolution of Biotechnology.

It’s no big surprise that what you tend to see on a daily basis in the realm of startup blogs, sites and otherwise material focuses on the mobile / the web / and new tech, this is simply due to the fact that these types of products are the most readily accessible by the consumer and therefore have the most mass media appeal.

Notwithstanding this invisible technological revolution is taking place at the same time as the ordinary tech one we see, hear about feel and touch on a daily basis; yet we deal with the invisible as well, where it affects us in ways unseen, it makes our lives better, makes us live longer, and helps not only us, but the environment.

This is Biotechnology. It’s unlike most anything else, not only because it’s “under the hood” of the media spotlight, nor because it can be anything from a geno-engineered microbe to a new form of high ethanol producing crops. It’s in its business model. You see, the web startup, or the software company can get a product to the shelf fairly quickly, with the web, if you have a good idea and some chips time to market can be as little as a few months if that, with biotech however, product development can take years, and oftentimes it will be a decade or more before the firm sees its first customer.

The biotech startup model is a complexly woven web which more than deserves its own analysis, and at the same time, and from the point of view of startup aficionados as ourselves it’s something breathtakingly beautiful.

So in the event you’re familiar with the industry, have a watch and enjoy, and if not, then welcome to the world which is Biotechnology. And a big thanks to the people at Europa Bio for putting this video together.